Finnish Genetics Study Provides Clues for Treating Type 2 Diabetes
A genetic mutation common to Finnish populations has been found to protect against type 2…
Although type 1 and type 2 diabetes have a huge impact on millions of people worldwide, there is still no cure for either condition. In diabetes, blood sugar levels are dysregulated. If untreated, high levels of blood sugar cause a range of symptoms that can have severe long-term effects. While treatments nowadays can help diabetics manage their symptoms, patients still face many long-term health complications.
Moreover, estimations suggest that the number of people affected by diabetes is steadily increasing worldwide. As a result, the World Health Organization considers diabetes an epidemic. Read on to gather more information about diabetes and how researchers are working on tackling the disease.
European Biotech Industry Report 2021
This report discusses how the Covid-19 pandemic impacted Europe’s life science industry and covers recent market trends, investments, and collaborations.
Go to Report
A genetic mutation common to Finnish populations has been found to protect against type 2…
Update (30/09/2019): A long legal battle between Adocia and Eli Lilly over a fast-acting insulin…
The first oral drug for type 2 diabetes belonging to the class of GLP-1 agonists,…
Six years ago, his three-year-old daughter was diagnosed with type 1 diabetes. This led Milos…
An immunotherapy designed by the Belgian biotech Imcyse to prevent type 1 diabetes has shown…
A plant extract developed by the French biotech Valbiotis is the first food supplement to…
A food supplement made from bacteria, developed by a Belgian research group, has improved symptoms…
The Belgian company Imcyse has raised €35M in a Series B round to develop a…
Up north in Stockholm, the Swedish company Biocrine aims to personalize diabetes treatments by screening…
An oral first-in-class drug targeting the mitochondria, developed by the French biotech Poxel, has shown…
Paris-based Cellnovo has cut down on staff as well as stopped manufacturing and selling its…
New advances in diabetes research are making it possible to develop a fully automated insulin…